Peter Duffy
Overview
Explore the profile of Peter Duffy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klein L, Harjai K, Resnic F, Weintraub W, Anderson H, Yeh R, et al.
Catheter Cardiovasc Interv
. 2016 Oct;
89(2):269-279.
PMID: 27755653
No abstract available.
2.
Ito H, Nussbaum M, Hermiller J, Hodes Z, Brodie B, Cheek B, et al.
EuroIntervention
. 2011 Feb;
6(8):942-8.
PMID: 21330241
Aims: Previous risk models predicting in-hospital major adverse cardiac or cerebrovascular events (MACCE) after percutaneous coronary interventions (PCI) may underestimate actual short-term post-procedure complications due to the trend toward early...
3.
Brodie B, Wilson H, Stuckey T, Nussbaum M, Laurent S, Bradshaw B, et al.
JACC Cardiovasc Interv
. 2009 Nov;
2(11):1105-12.
PMID: 19926052
Objectives: This study compares outcomes of drug-eluting stents (DES) versus bare-metal stents (BMS) in patients undergoing saphenous vein graft (SVG) intervention. Background: The safety and efficacy of DES in patients...
4.
Hawary A, Clarke L, Taylor A, Duffy P
Adv Urol
. 2009 Aug;
:591204.
PMID: 19657455
This report describes the case of an eighty-two-year old lady with an indwelling urethral catheter inserted eight years prior to her presentation to manage her urinary incontinence. She underwent radiotherapy...
5.
Brodie B, Stuckey T, Downey W, Humphrey A, Bradshaw B, Metzger C, et al.
JACC Cardiovasc Interv
. 2009 May;
1(4):405-14.
PMID: 19463338
Objectives: This study evaluates outcomes and complications in patients treated with drug-eluting stents (DES) for "off-label" indications. Background: Drug-eluting stents have been effective in randomized trials, but their safety and...
6.
Brodie B, Stuckey T, Downey W, Humphrey A, Nussbaum M, Laurent S, et al.
Catheter Cardiovasc Interv
. 2008 Nov;
72(7):893-900.
PMID: 19016465
Objectives: This study compares outcomes with drug-eluting stents (DES) versus bare metal stents (BMS) in patients with ST-elevation myocardial infarction (STEMI). Background: DESs have been effective in elective percutaneous coronary...
7.
Hawary A, Duffy P
ScientificWorldJournal
. 2008 Jul;
8:237-8.
PMID: 18661048
Urachal cysts are rare, can be one of the forgotten causes of abdominal pain, and can present as adenocarcinoma of the bladder, along with many other presentations. There is a...
8.
Simonton C, Brodie B, Cheek B, Krainin F, Metzger C, Hermiller J, et al.
J Am Coll Cardiol
. 2007 Sep;
50(13):1214-22.
PMID: 17888837
Objectives: The purpose of this study was to compare the 9-month clinical outcomes of patients treated with paclitaxel-eluting stents (PES) or sirolimus-eluting stents (SES) for coronary artery stenosis. Background: The...
9.
Aidoo A, Mittelstaedt R, Bishop M, Lyn-Cook L, Chen Y, Duffy P, et al.
Mutat Res
. 2003 Jun;
527(1-2):57-66.
PMID: 12787914
Caloric restriction (CR) reduces tumor incidence and retards aging in laboratory animals, including non-human primates. Because of the relationships among mutation, disease susceptibility, and aging, we investigated whether or not...
10.
Horvath R, Duffy P, McCormack J
Clin Infect Dis
. 2003 Mar;
36(7):869, 925-6.
PMID: 12659085
No abstract available.